KRP-M223

N/A

Report date: 2025/03/05 17:20:56
NME

Base Information

Drug NameKRP-M223
Drug Alias NameKRP-M223
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMRGPRX2 antagonists
TargetsMRGPRX2
Therapy Area/IndicationsInflammationAnaphylaxisChronic Urticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationAnaphylaxisChronic Urticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A